Suppr超能文献

ω-6 和 ω-3 多不饱和脂肪酸对高脂饮食诱导的肥胖和肝脏病理的差异干预作用。

Differential Interventional Effects of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on High Fat Diet-Induced Obesity and Hepatic Pathology.

机构信息

Laboratory for Lipid Medicine and Technology (LLMT), Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Department of Nursing and Allied Health Professions, Indiana University of Pennsylvania, Indiana, PA 15705, USA.

出版信息

Int J Mol Sci. 2023 Dec 8;24(24):17261. doi: 10.3390/ijms242417261.

Abstract

Current Dietary Guidelines for Americans recommend replacing saturated fat (SFA) intake with polyunsaturated fatty acids (PUFAs) and monosaturated fatty acids (MUFAs) but do not specify the type of PUFAs, which consist of two functionally distinct classes: omega-6 (n-6) and omega-3 (n-3) PUFAs. Given that modern Western diets are already rich in n-6 PUFAs and the risk of chronic disease remains high today, we hypothesized that increased intake of n-3 PUFAs, rather than n-6 PUFAs, would be a beneficial intervention against obesity and related liver diseases caused by high-fat diets. To test this hypothesis, we fed C57BL/6J mice with a high-fat diet (HF) for 10 weeks to induce obesity, then divided the obese mice into three groups and continued feeding for another 10 weeks with one of the following three diets: HF, HF+n-6 (substituted half of SFA with n-6 PUFAs), and HF+n-3 (substituted half of SFA with n-3 PUFAs), followed by assessment of body weight, fat mass, insulin sensitivity, hepatic pathology, and lipogenesis. Interestingly, we found that the HF+n-6 group, like the HF group, had a continuous increase in body weight and fat mass, while the HF+n-3 group had a significant decrease in body weight and fat mass, although all groups had the same calorie intake. Accordingly, insulin resistance and fatty liver pathology (steatosis and fat levels) were evident in the HF+n-6 and HF groups but barely seen in the HF+n-3 group. Furthermore, the expression of lipogenesis-related genes in the liver was upregulated in the HF+n-6 group but downregulated in the HF+n-3 group. Our findings demonstrate that n-6 PUFAs and n-3 PUFAs have differential effects on obesity and fatty liver disease and highlight the importance of increasing n-3 PUFAs and reducing n-6 PUFAs (balancing the n-6/n-3 ratio) in clinical interventions and dietary guidelines for the management of obesity and related diseases.

摘要

目前的《美国人膳食指南》建议用多不饱和脂肪酸(PUFAs)和单不饱和脂肪酸(MUFAs)取代饱和脂肪(SFA)的摄入量,但没有具体说明 PUFAs 的类型,它们由两种功能不同的类别组成:ω-6(n-6)和 ω-3(n-3)PUFAs。鉴于现代西方饮食中已经富含 n-6 PUFAs,而当今慢性病的风险仍然很高,我们假设增加 n-3 PUFAs 的摄入量而不是 n-6 PUFAs 的摄入量将是对抗肥胖和相关肝脏疾病的有益干预措施,这些疾病是由高脂肪饮食引起的。为了验证这一假设,我们用高脂肪饮食(HF)喂养 C57BL/6J 小鼠 10 周,以诱导肥胖,然后将肥胖小鼠分为三组,再用以下三种饮食中的一种喂养 10 周:HF、HF+n-6(用 n-6 PUFAs 替代一半 SFA)和 HF+n-3(用 n-3 PUFAs 替代一半 SFA),然后评估体重、脂肪量、胰岛素敏感性、肝病理和脂肪生成。有趣的是,我们发现 HF+n-6 组与 HF 组一样,体重和脂肪量持续增加,而 HF+n-3 组体重和脂肪量明显减少,尽管所有组的热量摄入相同。因此,HF+n-6 和 HF 组出现胰岛素抵抗和脂肪肝病理(脂肪变性和脂肪水平升高),而 HF+n-3 组几乎没有。此外,HF+n-6 组肝脏中与脂肪生成相关的基因表达上调,而 HF+n-3 组下调。我们的研究结果表明,n-6 PUFAs 和 n-3 PUFAs 对肥胖和脂肪肝疾病有不同的影响,并强调了在肥胖和相关疾病的临床干预和饮食指南中增加 n-3 PUFAs 和减少 n-6 PUFAs(平衡 n-6/n-3 比值)的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eef/10743920/c0b4026c1ee2/ijms-24-17261-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验